Abstract The purpose of this study was to find out how anxiety affects cancer detection and how early detection efforts are carried out in conjunction

Abstract  Disclosures Background:  A novel bio-physics based cancer detection technology named Cancer Differentiation Analysis Technology (CDA) has been developed and investigated for cancer treatment prognosis

Abstract ABSTRACT Background:  Routine health checkup is an essential strategy for monitoring population health and maintaining healthy workforces. However, there was a lack of cancer

Abstract

Background：While the current cancer screening methods mostly failed to detect cerebral cancer, a novel, promising technology named cancer differentiation analysis (CDA) technology has been developed to measure novel bio-physical properties to obtain valuable multi-level and multi-parameter information including protein, cellular and molecular level information. Initial results showed that CDA technology is capable of detecting cerebral cancer with a high degree of sensitivity and specificity.

Abstract

Background：Early stage cancer detection remains to be elusive despite of many years of efforts. In this work, a bio-physical based marker (named Cancer Differentiation Analysis (CDA)) with multi-level and multi-parameter expression features has been developed which has shown a number of clear advantages over the traditional approaches such as bio-chemistry based marker, circulating tumor cell (CTC) and circuiting DNA (ct-DNA). In stage I non-small cell lung cancer (NSCLC), sensitivity and specificity reached a record high of 85.2% and 93.0%, respectively.

Abstract

Background: Cervical cancer is the most common malignant tumor of female reproductive tract, with the second highest incidence in female malignant tumors and even the highest in some developing countries. Cervical cancer accounts for about 500,000 new cases worldwide each year, accounting for 5% of all new cases of cancer, more than 80% of which are in developing countries. The number of deaths of cervical cancer in China is about 53,000 per year, accounting for about 18.4% of all female malignant tumor deaths. Cervical cancer is a leading disease that endangers the health and life of women in China.